Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DY2GF8
|
|||
| Drug Name |
JNJ-77242113
|
|||
| Synonyms |
JNJ-2113
Click to Show/Hide
|
|||
| Indication | Psoriasis [ICD-11: EA90] | Phase 2 | [1] | |
| Company |
JOHNSON & JOHNSON
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05223868) A Phase 2b Multicenter, Randomized, Placebo Controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.